SUBORDINATION AGREEMENTSubordination Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Illinois
WHEREAS, GPSI Acquisition, Inc. and BioClinical Concepts, Inc. (collectively the "Borrowers"), are indebted to the Undersigned, as evidenced by a Credit Agreement, Security Agreement and Master Promissory Note in the face amount of $2,000,000.00, each dated as of July 1, 2002 (the "Junior Debt Instruments"), and will or may from time to time hereafter be otherwise indebted to the Undersigned in various sums;
Loan And Security Agreement Dated As Of March 31, 2003 Between LaSalle Business Credit, LLC The Lender, Clinical Data Inc. GPSI Acquisition, Inc. And BioClinical Concepts, Inc. The BorrowersLoan and Security Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Illinois
TRADEMARK SECURITY AGREEMENTTrademark Security Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Illinois
THIS TRADEMARK SECURITY AGREEMENT (the "Security Agreement") made as of this 31st day of March, 2003, by Clinical Data Inc., a Delaware corporation ("Borrower") in favor of LaSalle Business Credit, LLC, with an office at 135 South LaSalle Street, Suite 425, Chicago, Illinois 60603 ("Lender"):
AMENDMENT DATED AS OF APRIL 29, 2003 TO ASSET PURCHASE AGREEMENT DATED AS OF DECEMBER 9, 2002 (AS AMENDED) BY AND AMONG ELAN PHARMACEUTICALS, INC., ELAN DIAGNOSTICS, INC., NOVITRON INTERNATIONAL, INC. AND CLINICAL DATA INC. AMENDMENTAsset Purchase Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • New York
AMENDMENT dated as of April 29, 2003 (this "Amendment"), to ASSET PURCHASE AGREEMENT, dated as of December 9, 2002, as previously amended on February 10, 2003, March 18, 2003 and March 31, 2003 (the "Agreement"), by and among ELAN PHARMACEUTICALS, INC., a Delaware corporation ("Parent"), ELAN DIAGNOSTICS, INC., a Delaware corporation ("Seller"), NOVITRON INTERNATIONAL, INC., a Delaware corporation ("Buyer"), and CLINICAL DATA INC., a Delaware corporation ("Clinical Data").
AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER BY AND AMONG NOVITRON INTERNATIONAL, INC.; SPECTRAN HOLDINGS, INC.; AND LANDMARK SCIENTIFIC, INC. Dated as of April 29, 2003Agreement and Plan of Merger • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Delaware
AGREEMENT AND PLAN OF MERGER BY AND AMONG NOVITRON INTERNATIONAL, INC.; CLINICAL DATA INC.; AND GROUP PRACTICE SERVICES INCORPORATED Dated as of April 29, 2003Merger Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Delaware
PATENT SECURITY AgREEMENTPatent Security Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments • Illinois
THIS PATENT SECURITY AGREEMENT (the "Security Agreement") made as of this 31st day of March, 2003, by Clinical Data Inc., a Delaware corporation ("Borrower") in favor of LaSalle Business Credit, LLC with an office at 135 South LaSalle Street, Suite 425, Chicago, Illinois 60603 ("Lender"):
NOVITRON INTERNATIONAL, INC. One Gateway Center, Suite 411 Newton, MA 02458Asset Purchase Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments
We refer you to that certain Asset Purchase Agreement, dated as of December 9, 2002 (the "Asset Purchase Agreement"), by and among Elan Pharmaceuticals, Inc., a Delaware corporation ("Parent"), Elan Diagnostics, Inc., a Delaware corporation ("Seller") and Novitron International, Inc., a Delaware corporation ("Buyer").
Exhbit 10.2Loan and Security Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments
Clinical Data Inc., a Delaware corporation ("Clinical"), GPSI Acquisition, Inc., a Delaware corporation ("GPSI") and BioClinical Concepts, Inc., a Delaware Corporation ("BioClinical") (Clinical, GPSI and BioClinical are collectively referred to as "Borrowers") and LaSalle Business Credit, LLC, a Delaware limited liability company, ("Lender") have entered into that certain Loan and Security Agreement dated March 31, 2003 (the "Security Agreement"). From time to time thereafter, Borrowers and Lender may have executed various amendments (each an "Amendment" and collectively the "Amendments") to the Security Agreement (the Security Agreement and the Amendments hereinafter are referred to, collectively, as the "Agreement"). Borrowers and Lender now desire to further amend the Agreement as provided herein, subject to the terms and conditions hereinafter set forth.
ELAN PHARMACEUTICALS, INC. ELAN DIAGOSTICS, INC. c/o Elan Pharmaceuticals, Inc. 800 Gateway Boulevard South San Francisco, CA 94080Asset Purchase Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments
We refer you to the Asset Purchase Agreement, dated as of December 9, 2002, as amended (the "Asset Purchase Agreement"), by and among Elan Pharmaceuticals, Inc., a Delaware corporation, Elan Diagnostics, Inc., a Delaware corporation, and Novitron International, Inc., a Delaware corporation.
Re: Asset Purchase AgreementAsset Purchase Agreement • May 12th, 2003 • Novitron International Inc • Laboratory analytical instruments
We refer you to the Asset Purchase Agreement, dated as of December 9, 2002 (the "Asset Purchase Agreement"), by and among Elan Pharmaceuticals, Inc., a Delaware corporation, Elan Diagnostics, Inc., a Delaware corporation, and Novitron International, Inc., a Delaware corporation.
